OPKO Health
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · Florida, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
4400 Biscayne Blvd, Miami, Florida, 3313...Phone Number
(305) 575-4100Website
www.opko.comRevenue
$587.9 MillionStock Symbol
OPKIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About OPKO Health
OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics operations include a large clinical reference laboratory offering a broad range of testing services spanning molecular diagnostics, genetics, anatomical pathology, and women's health. Its pharmaceutical operations focus on developing and commercializing treatments across endocrinology and other therapeutic areas, as well as advancing multispecific antibody therapies for oncology and infectious disease through its biotechnology subsidiary. OPKO Health operates across the United States and internationally, with established pharmaceutical platforms in multiple countries. The company trades on the NASDAQ under the ticker symbol OPK.Explore more
OPKO Health Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OPKO Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OPKO Health recently announced quarterly report
Check if OPKO Health has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when OPKO Health launches new products
Check out if OPKO Health is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at OPKO Health
Funding: Get notified immidiatlly once OPKO Health has new funding data
Click to see if OPKO Health had a recent Job posting/layoffs
OPKO Health, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to OPKO Health
Compare insights from companies similar to OPKO Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
OPKO Health financials insights
Gather financial insights about OPKO Health, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$62.3M
2026
Debt
$125M
OPKO Health Tech Stack
A closer look at the technologies used by OPKO Health
See more technologies
Most Recent Scoops
Earnings
OPKO Health has reported total revenues of $163.6 million for Q2 2026, compared to $156.8 million in Q2 2025, with a consolidated operating loss of $7 million improving from a $60 million operating loss in Q2 2025, and a net loss of $8.4 million, or $0.01 per share, improving from a net loss of $148.4 million, or $0.19 per share, in Q2 2025.
Earnings, Finance
Earnings
OPKO Health has provided full year 2026 guidance with total revenue now expected to be between $560 million and $585 million, including revenue from services of $296 million to $306 million, pharmaceutical product revenue of $164 million to $174 million, and other revenue from partner collaboration agreements of $100 million to $105 million, with total costs and expenses expected to be in the range of $710 million to $740 million and full year R&D investment of $125 million to $135 million.
Earnings, Research & Development, Pharmaceuticals, Finance
Earnings
OPKO Health has provided Q3 2026 guidance with total revenue expected to be between $131 million and $142 million, including revenue from services of $75 million to $78 million, pharmaceutical product revenue of $40 million to $44 million, and IP and other revenue of $16 million to $20 million, with total costs and expenses expected to be between $180 million and $190 million and R&D investments of $34 million to $38 million.
Earnings, Research & Development, Pharmaceuticals, Finance
Project
OPKO Health announced that the scientific rationale for OPK-88006, its GLP-1 glucagon candidate, is based on glucagon's ability to trigger elevated FGF21 levels in addition to its own direct effects, creating an intra-molecular synergy that preclinical studies suggest may differentiate OPK-88006 from other GLP-1 glucagon class drugs, with FGF21 levels to be measured before and after treatment in clinical trials to confirm this effect.
Pharmaceuticals, Clinical Operations
Project
Medical Research, Pharmaceuticals
OPKO Health News & Media
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upsideCocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026OPKO Health Inc (OPK) Q2 2026 Earnings Call Highlights: Strong Pharmaceutical Growth and ...
OPKO Health Inc (OPK) reports significant revenue growth in pharmaceuticals and a notable reduction in net loss, despite challenges in diagnostics.OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
Conference Call to Begin Today at 4:30 p.m. ET Conference Call to Begin Today at 4:30 p.m. ET
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OPKO Health
Sign Up For FreeTo access detailed company insights
OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics... Read More
